215
Views
30
CrossRef citations to date
0
Altmetric
Review

Activity restriction in mild COPD: a challenging clinical problem

&
Pages 577-588 | Published online: 04 Jun 2014

References

  • Global Strategy for Diagnosis, Management, and Prevention of COPDGlobal initiative for chronic Obstructive Lung Disease (GOLD) updated 2014. Available from: http://www.goldcopd.org/Accessed January 27, 2014
  • Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood DiseasesBethesda, MDNational Heart, Lung, and Blood Institute2009 Available from: http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdfAccessed January 27, 2014
  • MapelDWDalalAABlanchetteCMPetersenHFergusonGTSeverity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claimsInt J Chron Obstruct Pulmon Dis2011657358122135490
  • BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax20086340240718234906
  • TroostersTSciurbaFBattagliaSPhysical inactivity in patients with COPD, a controlled multi-center pilot-studyRespir Med20101041005101120167463
  • Garcia-AymerichJLangePBenetMSchnohrPAntóJMRegular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort studyThorax20066177277816738033
  • ten HackenNHPhysical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease?Proc Am Thorac Soc2009666366720008872
  • BruunsgaardHPhysical activity and modulation of systemic low-level inflammationJ Leukoc Biol20057881983516033812
  • Garcia-AymerichJFarreroEFélezMAIzquierdoJMarradesRMAntóJMEstudi del Factors de Risc d’Agudització de la MPOC investigatorsRisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax20035810010512554887
  • GuenetteJAJensenDWebbKAOfirDRaghavanNO’DonnellDESex differences in exertional dyspnea in patients with mild COPD: physiological mechanismsRespir Physiol Neurobiol201117721822721524719
  • OfirDLavenezianaPWebbKALamYMO’DonnellDEMechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177662262918006885
  • DíazAAMoralesADíazJCCT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPDRespir Med201310757057923313036
  • ZuWallackRHow are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPDCOPD2007429329717729076
  • AnthonisenNRConnettJEMurrayRPSmoking and lung function of Lung Health Study participants after 11 yearsAm J Respir Crit Care Med200216667567912204864
  • AnthonisenNRSkeansMAWiseRAManfredaJKannerREConnettJEThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med200514223323915710956
  • QaseemAWiltTJWeinbergerSEAmerican College of PhysiciansAmerican College of Chest PhysiciansAmerican Thoracic SocietyEuropean Respiratory SocietyDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med201115517919121810710
  • O’DonnellDEAaronSBourbeauJCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 updateCan Respir J200714Suppl B5B32B
  • ChinRCGuenetteJAChengSDoes the respiratory system limit exercise in mild chronic obstructive pulmonary disease?Am J Respir Crit Care Med20131871315132323590271
  • McDonoughJEYuanRSuzukiMSmall-airway obstruction and emphysema in chronic obstructive pulmonary diseaseN Engl J Med20113651567157522029978
  • NiciLDonnerCWoutersEATS/ERS Pulmonary Rehabilitation Writing CommitteeAmerican Thoracic Society/European Respiratory Society statement on pulmonary rehabilitationAm J Respir Crit Care Med20061731390141316760357
  • PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200517197297715665324
  • O’DonnellDEVentilatory limitations in chronic obstructive pulmonary diseaseMed Sci Sports Exerc200133S647S65511462073
  • SaeyDMichaudACouillardAContractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20051711109111515735055
  • ManWDSolimanMGGearingJSymptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200316856256712829456
  • PalangePForteSOnoratiPManfrediFSerraPCarloneSVentilatory and metabolic adaptations to walking and cycling in patients with COPDJ Appl Physiol (1985)2000881715172010797134
  • PepinVSaeyDWhittomFLeBlancPMaltaisFWalking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20051721517152216166613
  • MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest20051281168117816162703
  • O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J20042383284015218994
  • O’DonnellDEVoducNFitzpatrickMWebbKAEffect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary diseaseEur Respir J200424869415293609
  • MatsuokaSWashkoGRDransfieldMTQuantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitationAcad Radiol201017939919796970
  • RambodMPorszaszJMakeBJCrapoJDCasaburiRSix-minute walk distance predictors, including CT scan measures, in the COPDGene cohortChest201214186787521960696
  • YuanRHoggJCParéPDPrediction of the rate of decline in FEV(1) in smokers using quantitative computed tomographyThorax20096494494919734130
  • DeesomchokAWebbKAForkertLLung hyperinflation and its reversibility in patients with airway obstruction of varying severityCOPD2010742843721166631
  • GagnonPGuenetteJALangerDPathogenesis of hyperinflation in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014918720124600216
  • HoggJCMacklemPTThurlbeckWMSite and nature of airway obstruction in chronic obstructive lung diseaseN Engl J Med1968278135513605650164
  • HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
  • BlackLFHyattREStubbsSEMechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with 1-antitrypsin deficiencyAm Rev Respir Dis19721058918995032709
  • LeaverDGTatterfieldAEPrideNBContributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysemaJ Clin Invest197352211721284727452
  • MitznerWEmphysema – a disease of small airways or lung parenchyma?N Engl J Med20113651637163922029986
  • CorbinRPLovelandMMartinRRMacklemPTA four-year follow-up study of lung mechanics in smokersAm Rev Respir Dis1979120293304475151
  • BarberaJARamirezJRocaJWagnerPDSanchez-LloretJRodriguez-RoisinRLung structure and gas exchange in mild chronic obstructive pulmonary diseaseAm Rev Respir Dis19901418959012327653
  • BarberàJARiverolaARocaJPulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19941494234298306040
  • Rodríguez-RoisinRDrakulovicMRodríguezDARocaJBarberàJAWagnerPDVentilation-perfusion imbalance and chronic obstructive pulmonary disease staging severityJ Appl Physiol (1985)20091061902190819372303
  • SantosSPeinadoVIRamírezJCharacterization of pulmonary vascular remodelling in smokers and patients with mild COPDEur Respir J20021963263811998991
  • O’DonnellDELavenezianaPOraJWebbKALamYMOfirDEvaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPDThorax20096421622319052054
  • O’DonnellDEMaltaisFPorszaszJLung function and exercise impairment in patients with GOLD stage I and II COPDAm J Respir Crit Care MedConference18–23 May, 2012San Francisco, California, USA Abstr. No. D80
  • PeinadoVIBarberaJARamirezJEndothelial dysfunction in pulmonary arteries of patients with mild COPDAm J Physiol1998274L908L9139609729
  • BorgGAPsychophysical bases of perceived exertionMed Sci Sports Exerc19821453773817154893
  • McParlandCMinkJGallagherCGRespiratory adaptations to dead space loading during maximal incremental exerciseJ Appl Physiol (1985)19917055622010409
  • O’DonnellDEHongHHWebbKARespiratory sensation during chest wall restriction and dead space loading in exercising menJ Appl Physiol (1985)2000881859186910797151
  • SyabbaloNCZintelTWattsRGallagherCGCarotid chemoreceptors and respiratory adaptations to dead space loading during incremental exerciseJ Appl Physiol (1985)199375137813848226554
  • BrownSEKingRRTemerlinSMStansburyDWMahutteCKLightRWExercise performance with added dead space in chronic airflow obstructionJ Appl Physiol Respir Environ Exerc Physiol198456102010266427144
  • BarrRGBluemkeDAAhmedFSPercent emphysema, airflow obstruction, and impaired left ventricular fillingN Engl J Med201036221722720089972
  • GrauMBarrRGLimaJAPercent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle StudiesChest201314413614423450302
  • MalerbaMRagnoliBSalamehMSub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary diseaseJ Biol Regul Homeost Agents20112544345122023769
  • ManninoDMDohertyDESonia BuistAGlobal Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) studyRespir Med200610011512215893923
  • SabitRBoltonCEFraserAGSub-clinical left and right ventricular dysfunction in patients with COPDRespir Med20101041171117820185285
  • SmithBMKawutSMBluemkeDAPulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD StudyCirculation20131271503151123493320
  • ThomashowMAShimboDParikhMAEndothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease studyAm J Respir Crit Care Med2013188606823600492
  • LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med201218697598122997207
  • RoigMEngJJMacIntyreDLRoadJDReidWDDeficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary diseaseJ Cardiopulm Rehabil Prev20113112012421037481
  • Orozco-LeviMCoronellCRamírez-SarmientoAInjury of peripheral muscles in smokers with chronic obstructive pulmonary diseaseUltrastruct Pathol20123622823822849524
  • van den BorstBSlotIGHellwigVALoss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPDJ Appl Physiol (1985)20131141319132822815389
  • ClarkCJCochraneLMMackayEPatonBSkeletal muscle strength and endurance in patients with mild COPD and the effects of weight trainingEur Respir J200015929710678627
  • SeymourJMSpruitMAHopkinsonNSThe prevalence of quadriceps weakness in COPD and the relationship with disease severityEur Respir J201036818819897554
  • VogiatzisIZakynthinosSThe physiological basis of rehabilitation in chronic heart and lung diseaseJ Appl Physiol (1985)2013115162123620491
  • PittaFTroostersTProbstVSSpruitMADecramerMGosselinkRQuantifying physical activity in daily life with questionnaires and motion sensors in COPDEur Respir J2006271040105516707399
  • MooreRBerlowitzDDenehyLJacksonBMcDonaldCFComparison of pedometer and activity diary for measurement of physical activity in chronic obstructive pulmonary diseaseJ Cardiopulm Rehabil Prev200929576119158589
  • MaltaisFExercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategiesPhys Sportsmed201341668023445862
  • Le MasurierGCTudor-LockeCComparison of pedometer and accelerometer accuracy under controlled conditionsMed Sci Sports Exerc20033586787112750599
  • PittaFTroostersTSpruitMADecramerMGosselinkRActivity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary diseaseArch Phys Med Rehabil2005861979198516213242
  • PatelSABenzoRPSlivkaWASciurbaFCActivity monitoring and energy expenditure in COPD patients: a validation studyCOPD2007410711217530503
  • WatzHWaschkiBMeyerTMagnussenHPhysical activity in patients with COPDEur Respir J20093326227219010994
  • WaschkiBKirstenAHolzOPhysical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort studyChest201114033134221273294
  • LacasseYMartinSLassersonTJGoldsteinRSMeta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic reviewEura Medicophys20074347548518084170
  • WorthHFörsterKErikssonGNihlénUPetersonSMagnussenHBudesonide added to formoterol contributes to improved exercise tolerance in patients with COPDRespir Med20101041450145920692140
  • MaltaisFCelliBCasaburiRAclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPDRespir Med201110558058721183326
  • O’DonnellDECasaburiRVinckenWEffect of indacaterol on exercise endurance and lung hyperinflation in COPDRespir Med20111051030103621498063
  • BorelBProvencherSSaeyDMaltaisFResponsiveness of various exercise-testing protocols to therapeutic interventions in COPDPulm Med2013201341074823431439
  • BelferMHReardonJZImproving exercise tolerance and quality of life in patients with chronic obstructive pulmonary diseaseJ Am Osteopath Assoc200910926827819451260
  • GarrodRBestallJCPaulEAWedzichaJAJonesPWDevelopment and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL)Respir Med20009458959610921765
  • Janaudis-FerreiraTBeauchampMKRoblesPGGoldsteinRSBrooksDMeasurement of activities of daily living in patients with COPD: a systematic reviewChest201414525327123681416
  • DohertyDEBelferMHBruntonSAFromerLMorrisCMSnaderTCChronic obstructive pulmonary disease: consensus recommendations for early diagnosis and treatmentJ Fam Pract Clinical update200655SupplS1S8
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J20093464865419720809
  • JonesPWBrusselleGDal NegroRWProperties of the COPD assessment test in a cross-sectional European studyEur Respir J201138293521565915
  • PowrieDJThe BODE index: a new grading system in COPDThorax200459427
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med200216611111712091180
  • SolwaySBrooksDLacasseYThomasSA qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domainChest200111925627011157613
  • GolpeRPérez-de-LlanoLAMéndez-MaroteLVeres-RacamondeAPrognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patientsRespir Care2013581329133423322886
  • CasanovaCCoteCMarinJMDistance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPDChest200813474675218625667
  • Pinto-PlataVMCoteCCabralHTaylorJCelliBRThe 6-min walk distance: change over time and value as a predictor of survival in severe COPDEur Respir J200423283314738227
  • IlginDOzalevliSKilincOSevincCCimrinAHUcanESGait speed as a functional capacity indicator in patients with chronic obstructive pulmonary diseaseAnn Thorac Med2011614114621760846
  • MorganMDSinghSJAssessing the exercise response to a bronchodilator in COPD: time to get off your bike?Thorax20076228128317387209
  • SinghSJMorganMDScottSWaltersDHardmanAEDevelopment of a shuttle walking test of disability in patients with chronic airways obstructionThorax199247101910241494764
  • RevillSMMorganMDSinghSJWilliamsJHardmanAEThe endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary diseaseThorax19995421322210325896
  • PepinVBrodeurJLacasseYSix-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary diseaseThorax20076229129817099077
  • BrouillardCPepinVMilotJLacasseYMaltaisFEndurance shuttle walking test: responsiveness to salmeterol in COPDEur Respir J20083157958418057052
  • BoerLMAsijeeGMvan SchayckOCSchermerTRHow do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD?Prim Care Respir J20122120220722453664
  • O’DonnellDEMaltaisFPorszaszJThe continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trialPLoS ONE201495e9657424788342
  • MaltaisFDennisNChanCKRationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPDCOPD2013107910323272663
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
  • DecramerMCelliBKestenSLystigTMehraSTashkinDPUPLIFT investigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet20093741171117819716598
  • JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
  • BelmanMJBotnickWCShinJWInhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19961539679758630581
  • O’DonnellDESciurbaFCelliBEffect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPDChest200613064765616963658
  • PetersMMWebbKAO’DonnellDECombined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPDThorax20066155956716467067
  • RaghavanNGuenetteJAO’DonnellDEThe role of pharmacotherapy in mild to moderate chronic obstructive pulmonary diseaseTher Adv Respir Dis2011524525421357348
  • FergusonGTMaintenance pharmacotherapy of mild and moderate COPD: what is the evidence?Respir Med20111051268127421353516
  • GagnonPSaeyDProvencherSWalking exercise response to bronchodilation in mild COPD: a randomized trialRespir Med20121061695170522999808
  • NiciLLareauSZuWallackRPulmonary rehabilitation in the treatment of chronic obstructive pulmonary diseaseAm Fam Physician20108265566020842995
  • TselebisABratisDPachiAA pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patientsMultidiscip Respir Med201384123931626
  • BratåsOEspnesGARannestadTWalstadRPulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients – especially in patients with mild or moderate diseaseChron Respir Dis2010722923721084547
  • ChavannesNVollenbergJJvan SchayckCPWoutersEFEffects of physical activity in mild to moderate COPD: a systematic reviewBr J Gen Pract20025257457812120732
  • JácomeCIMarquesASPulmonary rehabilitation for mild chronic obstructive pulmonary disease: A systematic reviewRespir Care2014459458859424106321
  • MartinezFJRaczekAESeiferFDCOPD-PS Clinician Working GroupDevelopment and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS)COPD20085859518415807